Fluvoxamine
Back to searchMolecule Structure
Scientific Name
Fluvoxamine
Description of the Drug
Fluvoxamine is a selective serotonin-reuptake inhibitor used to treat obsessive-compulsive disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00176
http://www.drugbank.ca/drugs/DB00176
Brand Name(s)
Not Available
Company Owner(s)
Teva Pharmaceuticals Usa Inc, Apotex Inc, Sun Pharmaceutical Industries Inc, Torrent Pharmaceuticals Ltd, Jazz Pharmaceuticals Inc, Chartwell Rx Sciences Llc, Upsher Smith Laboratories Llc, Actavis Elizabeth Llc, Bionpharma Inc, Anchen Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Serotonin transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL228 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL33983 | ||
| DrugBank | DB00176 | ||
| PubChem: Thomson Pharma | 14899201 | ||
| PubChem | 5324346 | ||
| PDBe | FVX | ||
| BindingDB | 50028091 | ||
| EPA CompTox Dashboard | DTXSID2044002 | ||
| DrugCentral | 1230 | ||
| Brenda | 145967 | 75624 | 145053 |
| ChemicalBook | CB8468990 | ||
| Guide to Pharmacology | 7189 | ||
| rxnorm | FLUVOXAMINE MALEATE | FLUVOXAMINE | LUVOX |
| KEGG Ligand | C07571 | ||
| ChEBI | 5138 | ||
| ZINC | ZINC000003872605 |
